Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fucosylated Glycoproteins as Markers of Liver Disease

1 Jan 2008

Abstract excerpt

Changes in N-linked glycosylation are known to occur during the development of various diseases. For example, increased branching of oligosaccharides has been associated with cancer metastasis and has been correlated to tumor progression in human cancers of the breast, colon and melanomas. Increases in core fucosylation have also been associated with the development of hepatocellular carcinoma (HCC). Recently,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Galectins and Cancer Biology
Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19126969
DOI: 10.1155/2008/264594

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fucosylated Glycoproteins as Markers of Liver DiseasePMID 19126969Read ↗

Evaluation of the serum <b> <i>N</i> </b> ‐linked glycome for the diagnosis of cancer and chronic inflammationSemantic proximity Read ↗

Blood<i>N</i>-glycomic signature of fibrosis in MASLD shows low levels of global α2,3-sialylationSemantic proximity Read ↗

Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer typesSemantic proximity Read ↗

IgG N-glycan Signatures as Potential Diagnostic and Prognostic BiomarkersSemantic proximity Read ↗

Integrating Transcriptomics, Glycomics And Glycoproteomics To Characterize Hepatitis B Virus-associated Hepatocellular CarcinomaSemantic proximity Read ↗

Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeuticsSemantic proximity Read ↗

Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver DiseasesSemantic proximity Read ↗

Immunoglobulin G glycosylation in aging and diseasesSemantic proximity Read ↗

Immunoglobulin G glycosylation and its alterations in aging-related diseasesSemantic proximity Read ↗

Profiling IgG N-glycans as potential biomarker of chronological and biological agesSemantic proximity Read ↗

Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert reviewSemantic proximity Read ↗

Serum glycoprotein markers in non-alcoholic steato-hepatitis and hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.